Cited by

• Galactosemia among Positive-screened Patients who Underwent Lactose Challenge: A Review of Records of the Newborn Screening Program.

  Orteza MEV, Abacan MAR. Orteza MEV, et al. Acta Med Philipp. 2024 Oct 15;58(18):56-63. doi: 10.47895/amp.vi0.8179. eCollection 2024. Acta Med Philipp. 2024. PMID: 39483312 Free PMC article.
• Evaluation of 3-methylcrotonyl-CoA carboxylase deficiency detected by tandem mass spectrometry newborn screening.

  Koeberl DD, Millington DS, Smith WE, Weavil SD, Muenzer J, McCandless SE, Kishnani PS, McDonald MT, Chaing S, Boney A, Moore E, Frazier DM. Koeberl DD, et al. J Inherit Metab Dis. 2003;26(1):25-35. doi: 10.1023/a:1024015227863. J Inherit Metab Dis. 2003. PMID: 12872837
• Parents' views on accepting, declining, and expanding newborn bloodspot screening.

  van der Pal SM, Wins S, Klapwijk JE, van Dijk T, Kater-Kuipers A, van der Ploeg CPB, Jans SMPJ, Kemp S, Verschoof-Puite RK, van den Bosch LJM, Henneman L. van der Pal SM, et al. PLoS One. 2022 Aug 18;17(8):e0272585. doi: 10.1371/journal.pone.0272585. eCollection 2022. PLoS One. 2022. PMID: 35980961 Free PMC article.
• Factors associated with parental perception of child vulnerability 12 months after abnormal newborn screening results.

  Tluczek A, McKechnie AC, Brown RL. Tluczek A, et al. Res Nurs Health. 2011 Oct;34(5):389-400. doi: 10.1002/nur.20452. Epub 2011 Aug 24. Res Nurs Health. 2011. PMID: 21910128 Free PMC article.
• Public attitudes regarding the use of residual newborn screening specimens for research.

  Botkin JR, Rothwell E, Anderson R, Stark L, Goldenberg A, Lewis M, Burbank M, Wong B. Botkin JR, et al. Pediatrics. 2012 Feb;129(2):231-8. doi: 10.1542/peds.2011-0970. Epub 2012 Jan 16. Pediatrics. 2012. PMID: 22250018 Free PMC article.